The CD40-CD154 interaction in B cell-T cell liaisons

Cytokine and Growth Factor Reviews

Volumn 14, Issue 3-4, 2003, Pages 297-309

  Bishop, Gail A ^a,b,c   Hostager, Bruce S ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

B lymphocyte; Signal transduction; T lymphocyte; TNF R family

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; IMMUNOGLOBULIN; LYMPHOKINE; PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; B LYMPHOCYTE; CELL TYPE; ENZYME ACTIVATION; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0038658816     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(03)00024-8     Document Type: Review

References (172)

1. Paulie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H, Perlmann P. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother 1985;20:23-8.
2. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993;361:541-3.
3. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen FS, Chatila T, et al. Defective expression of the CD40 ligand in X chromosome-linked Ig deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 1993;90:2170-3.
4. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993;361:539-41.
5. Callard RE, Armitage RJ, Fanslow WC, Spriggs MK. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 1993;14:559-64.
6. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992;89:6550-4.
7. Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 1992;22:2573-8.
8. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992;11:4313-21.
9. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992;357:80-2.
10. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, et al. The immune responses in CD40-deficient mice: impaired Ig class switching and germinal center formation. Immunity 1994;1:167-78.
11. Xu J, Foy TM, Laman JD, Elliott EA, Dunn JJ, Waldschmidt TJ, et al. Mice deficient for the CD40 ligand. Immunity 1994;1:423-31.
12. Castigli E, Alt FW, Davidson L, Bottaro A, Mizoguchi E, Bhan AK, et al. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci USA 1994;91:12135-9.
13. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995;378:617-20.
14. van Essen D, Kikutani H, Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995;378:620-3.
15. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40L is required for protective cell-mediated immunity to Leishmania major. Immunity 1996;4:283-9.
16. + T-cell responses. Immunol Today 1996;17:410-4.
17. Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, et al. Requirement for CD40L in costimulation induction, T cell activation, and EAE. Science 1996;273:1864-7.
18. Holländer GA, Castigli E, Kulbacki R, Su M, Burakoff SJ, Gutierrez-Ramos J-C, et al. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proc Natl Acad Sci USA 1996;93:4994-8.
19. Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, et al. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996;4:275-81.
20. Soong L, Xu J-C, Grewal IS, Kima P, Sun J, Longley BJ, et al. Disruption of CD40-CD40L interactions results in an enhanced susceptibility to Leishmania amazonesis infection. Immunity 1996;4:263-73.
21. Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 1996;156:8-11.
22. Maruo S, Oh-hora M, Ahn H-J, Ono S, Wysocka M, Kaneko Y, et al. B cells regulate CD40L-induced IL-12 production in APC during T cell/APC interactions. J Immunol 1997;158:120-6.
23. Moodycliffe AM, Shreedhar V, Ulrich SE, Walterscheid J, Bucana C, Kripke ML, et al. CD40-CD40L interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J Exp Med 2000;191:2011-20.
24. Brines RD, Klaus GGB. Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand. Int Immunol 1993;5:1445-50.
25. Wheller K, Pound JD, Gordon J, Jefferis R. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur J Immunol 1993;23:1165-8.
26. low T cells. Eur J Immunol 1994;24:2993-9.
27. Bishop GA, Warren WD, Berton MT. Signaling via MHC class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand. Eur J Immunol 1995;25:1230-8.
28. Urashima M, Chauhan D, Hatziyanni M, Ogata A, Hollenbaugh D, Aruffo A, et al. CD40L triggers IL-6 mediated B cell differentiation. Leuk Res 1996;20:507-15.
29. Busch LK, Bishop GA. The EBV transforming protein, LMP1, mimics and cooperates with CD40 signaling in B lymphocytes. J Immunol 1999;162:2555-61.
30. Bishop GA, Ramirez LM, Baccam M, Busch LK, Pederson LK, Tomai MA. The immune response modifier, Resiquimod, mimics CD40-induced B cell activation. Cell Immunol 2001;208:9-17.
31. Hostager BS, Bishop GA. Role of TRAF2 in the activation of IgM secretion by CD40 and CD120b. J Immunol 2002;168:3318-22.
32. Worm M, Geha RS. CD40 ligation induces lymphotoxin a gene expression in human B cells. Int Immunol 1994;6:1883-90.
33. Worm M, Geha RS. Activation of TNF-α and lymphotoxin-β via anti-CD40 in human B cells. Int Arch Allergy Immunol 1995;107:368-9.
34. Worm M, Geha RS. CD40-mediated lymphotoxin a expression in human B cells is tyrosine kinase dependent. Eur J Immunol 1995;25:2438-44.
35. + IL-4-mediated B cell activation in normal and atopic donors. Immunology 1998;94:395-402.
36. Burdin N, Van Kooten C, Galibert L, Abrams JS, Wijdenes J, Banchereau J, et al. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol 1995;154:2533-44.
37. Skok J, Poudrier J, Gray D. DC-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development. J Immunol 1999;163:4284-91.
38. Schaniel C, Pardali E, Sallusto F, Speletas M, Ruedl C, Shimizu T, et al. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J Exp Med 1998;188:451-63.
39. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of IL-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-52.
40. Marovich MA, McDowell MA, Thomas EK, Nutman TB. IL-12p70 production by Leishmania major-harboring human DC is a CD40/CD40L-dependent process. J Immunol 2000;164:5858-65.
41. Kupfer A, Swain SL, Siinger SJ. The specific direct interaction of helper T cells and antigen-presenting B cells. J Exp Med 1987;165:1565-80.
42. Ronchese F, Hausmann B. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J Exp Med 1993;177:679-90.
43. + T cells to protein antigens in vivo. J Immunol 1995;155:3734-41.
44. Mason D. The role of B cells in the programming of T cells for IL-4 synthesis. J Exp Med 1996;183:717-9.
45. Chan O, Shlomchik MJ. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-1pr/1pr mice. J Immunol 1998;160:51-9.
46. Macaulay AE, DeKruyff RH, Umetsu DT. Antigen-primed T cells from B cell-deficient JHD mice fail to provide B cell help. J Immunol 1998;160:1694-700.
47. + T cell priming in vivo. J Immunol 1999;162:5695-703.
48. Rivera A, Chen C-C, Ron N, Dougherty JP, Ron Y. Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol. 2001;13:1583-93.
49. Yang Y, Wilson JM. CD40L-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 1996;273:1862-4.
50. Gurunathan S, Irvine KR, Wu C, Cohen JI, Thomas E, Prussin C, et al. CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J Immunol 1998;161:4563-71.
51. Ranheim EA, Kipps TJ. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 1993;177:925-35.
52. Han S, Hathcock K, Zheng B, Kepler TB, Hodes R, Kelsoe G. Cellular interaction in germinal centers. Roles of CD40L and B7-2 in established germinal centers. J Immunol 1995;155:556-67.
53. Nishioka Y, Lipsky PE. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J Immunol 1994;153:1027-36.
54. Barrett TB, Shu G, Clark EA. CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J Immunol 1991;146:1722-9.
55. Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J. IL-10 and TGFβ cooperate to induce anti-CD40-activated naive human B cells to secrete IgA. J Exp Med 1992;175:671-82.
56. Gauchat J-F, Aversa G, Gascan H, de Vries JE. Modulation of IL-4 induced germline ε RNA synthesis in human B cells by TNF-α, anti-CD40 mAb or TGF-β correlates with levels of IgE production. Int Immunol 1992;4:397-406.
57. Shapira SK, Vercelli D, Jabara HH, Fu SM, Geha RS. Molecular analysis of the induction of IgE synthesis in human B cells by IL-4 and engagement of CD40 antigen. J Exp Med 1992;175:289-92.
58. Jumper MD, Splawski JB, Lipsky PE, Meek K. Ligation of CD40 induces sterile transcripts of multiple Ig H chain isotypes in human B cells. J Immunol 1994;152:438-45.
59. Warren W, Berton MT. Germline Ig transcript expression in murine B cells stimulated with baculovirus-expressed CD40L. Fed Proc 1994;8:5863.
60. Warren WD, Berton MT. Induction of germ-line γ1 and ε Ig gene expression in murine B cells. IL-4 and the CD40L-CD40 interaction provide distinct but synergistic signals. J Immunol 1995;155:5637-46.
61. Lin S-C, Stavnezer J. Activation of NF-κB/Rel by CD40 engagement induces the mouse germ line Ig Cγ1 promoter. Mol Cell Biol 1996;16:4591-603.
62. Zelazowski P, Max EE, Kehry MR, Snapper CM. Regulation of Ku expression in normal murine B cells by stimuli that promote switch recombination. J Immunol 1997;159:2559-62.
63. Shen C, Stavnezer J. Interaction of Stat6 and NF-κB: direct association and synergistic activation of IL-4-induced transcription. Mol Cell Biol 1998;18:3395-404.
64. Morio T, Hanissian SH, Bacharier LB, Teraoka H, Nonoyama S, Seki M, et al. Ku in the cytoplasm associates with CD40 in human B cells and translocates into the nucleus following incubation with IL-4 and anti-CD40 mAb. Immunity 1999;11:339-48.
65. Tangye SG, Ferguson A, Avery DT, Ma CS, Hodgkin PD. Isotype switching by human B cells is division-associated and regulated by cytokines. J Immunol 2002;169:4298-306.
66. Hasbold J, Lyons AB, Kehry MR, Hodgkin PD. Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40L and IL-4. Eur J Immunol 1998;28:1040-51.
67. Iciek LA, Delphin SA, Stavnezer J. CD40 cross-linking induces Igε germline transcripts in B cells via activation of NF-κB. Synergy with IL-4 induction. J Immunol 1997;158:4769-79.
68. Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Noelle RJ. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 1994;180:157-63.
69. Grouard G, de Bouteiller O, Barthelemy C, Lebecque S, Banchereau J, Liu Y-J. Regulation of human B cell activation by FDC and T cell signals. Curr Top Microbiol Immunol 1996;201:107-17.
70. Tsiagbe VK, Inghirami G, Thorbecke GJ. The physiology of germinal centers. CRC Crit Rev Immunol 1996;16:381-421.
71. Miyashita T, McIlraith MJ, Grammer AC, Miura Y, Attrep JF, Shimaoka Y, et al. Bidirectional regulation of human B cell responses by CD40-CD40L interactions. J Immunol 1997;158:4620-33.
72. Blossom S, Chu EB, Weigle WO, Gilbert KM. CD40L expressed on B cells in the BXSB mouse model of SLE. J Immunol 1997;159:4580-6.
73. Koshy M, Berger D, Crow MK. Increased expression of CD40 ligand on SLE lymphocytes. J Clin Invest 1996;98:826-32.
74. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40L by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996;97:2063-73.
75. Higuchi T, Aiba Y, Nomura T, Matsuda J, Mochida K, Suzuki M, et al. Cutting edge: ectopic expression of CD40L on B cells induces lupus-like autoimmune disease. J Immunol 2002;168:9-12.
76. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, et al. The CD40 antigen and its ligand. Ann Rev Immunol 1994;12:881-922.
77. Fanslow WC, Clifford KN, Seaman M, Alderson MR, Spriggs MK, Armitage RJ, et al. Recombinant CD40 ligand exerts potent biologic effects on T cells. J Immunol 1994;152:4262-9.
78. Wagner DH, Vaitaitis G, Sanderson R, Poulin M, Dobbs C, Haskins K. Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc Natl Acad Sci USA 2002;99:3782-7.
79. + T cell memory. Science 2002;297:2060-3.
80. Hu HM, O'Rourke K, Boguski MS, Dixit VM. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 1994;269:30069-72.
81. Arch RH, Gedrich RW, Thompson CB. TRAFs - a family of adapter proteins that regulates life and death. Genes Dev 1998;12:2821-30.
82. Ishida T, Tojo T, Aoki T, Kobayashi N, Ohishi T, Watanabe T, et al. TRAF5, a novel TNF-R-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci USA 1996;93:9437-42.
83. Nakano H, Oshima H, Chung W, Williams-Abbott L, Ware CF, Yagita H, et al. TRAF5, an activator of NF-κB and putative signal transducer for the LT-β receptor. J Biol Chem 1996;271:14661-4.
84. Nakano H, Sakon S, Koseki H, Takemori T, Tada K, Matsumoto M, et al. Targeted disruption of Traf5 gene causes defects in CD40 and CD27-mediated lymphocyte activation. Proc Natl Acad Sci USA 1999;96:9803-8.
85. Bishop GA, Hostager BS, Brown KD. Mechanisms of tumor necrosis factor receptor associated factor (TRAF) regulation in B lymphocytes. J Leuk Biol 2002;72:19-23.
86. Haxhinasto SA, Hostager BS, Bishop GA. Cutting edge: molecular mechanisms of synergy between CD40 and the BCR: role for TRAF2 in receptor interaction. J Immunol 2002;169:1145-9.
87. Inui S, Kaisho T, Kikutani H, Stamenkovic I, Seed B, Clark EA, et al. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur J Immunol 1990;20:1747-53.
88. Hostager BS, Hsing Y, Harms DE, Bishop GA. Different CD40-mediated signaling events require distinct CD40 structural features. J Immunol 1996;157:1047-53.
89. Goldstein MD, Watts TH. Identification of distinct domains in CD40 involved in B7-1 induction or growth inhibition. J Immunol 1996;157:2837-43.
90. Watts TH, Alaverdi N, Wade WF, Linsley PS. Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction. J Immunol 1993;150:2192-202.
91. Xu Y, Cheng G, Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 1996;5:407-15.
92. Yeh W, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997;7:715-25.
93. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, et al. TRAF6 deficiency results in osteopetrosis and defective IL-1, CD40, and LPS signaling. Genes Dev 1999;13:1015-21.
94. Hsing Y, Hostager BS, Bishop GA. Characterization of CD40 signaling determinants regulating NF-κB activation in lymphocytes. J Immunol 1997;159:4898-906.
95. Homung M, Lindemann D, Kraus C, Peters A, Berberich I. The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IgM-induced growth arrest. Eur J Immunol 1998;28:3812-23.
96. Jalukar SV, Hostager BS, Bishop GA. Characterization of the roles of TRAF6 in CD40-mediated B lymphocyte effector functions. J Immunol 2000;164:623-30.
97. Yasui T, Muraoka M, Takaoka-Shichijo Y, Ishida I, Takegahara N, Uchida J, et al. Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals. Int Immunol 2002;14:319-29.
98. Ahonen CL, Manning EM, Erickson LD, O'Connor BP, Lind EF, Pullen SS, et al. The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat Immunol 2002;3:451-6.
99. Jabara HH, Laouini D, Tsitsikov E, Mizoguchi E, Bhan AK, Castigli E, et al. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated Ig class switching. Immunity 2002;17:265-76.
100. Grammer AC, Swantek JL, McFarland RD, Miura Y, Geppert T, Lipsky PE. TRAF3 signaling mediates activation of p38 and JNK, cytokine secretion, and Ig production following ligation of CD40 on human B cells. J Immunol 1998;161:1183-93.
101. Cheng G, Cleary AM, Ye Z, Hong DI, Lederman S, Baltimore D. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 1995;267:1494-8.
102. Hostager BS, Bishop GA. Cutting edge: contrasting roles of TRAF2 and TRAF3 in CD40-mediated B lymphocyte activation. J Immunol 1999;162:6307-11.
103. Lee SY, Reichlin A, Santana A, Sokol KA, Nussenzweig MC, Choi Y. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 1997;7:701-13.
104. Hostager BS, Haxhinasto SA, Rowland SR, Bishop GA. Roles of TRAF2 in B cell signaling: new insights gained from development and use of TRAF-deficient B cell lines [manuscript submitted].
105. Kuhné MR, Robbins M, Hambor JE, Mackey MF, Kosaka Y, Nishimura T, et al. Assembly and regulation of the CD40 receptor complex in human B cells. J Exp Med 1997;186:337-42.
106. Hostager BS, Catlett IM, Bishop GA. Recruitment of CD40, TRAF2 and TRAF3 to membrane microdomains during CD40 signaling. J Biol Chem 2000;275:15392-8.
107. Bishop GA, Hostager BS. Molecular mechanisms of CD40 signaling. Arch Immun Ther Exp 2001;49:129-37.
108. Brown KD, Hostager BS, Bishop GA. Differential signaling and TRAF degradation by CD40 and the EBV oncoprotein LMP1. J Exp Med 2001;193:943-54.
109. Brown KD, Hostager BS, Bishop GA. Regulation of TRAF2 signaling by self-induced degradation. J Biol Chem 2002;277:19433-8.
110. Yuasa T, Ohno S, Kehrl JH, Kyriakis JM. TNF signaling to SAPK/JNK and p38. Germinal center kinase couples TRAF2 to MAPK/ERK kinase kinase-1 and SAPK while RIP associates with a MAPKKK upstream of MKK6 and p38. J Biol Chem 1998;273:22681-92.
111. Shi C, Leonardi A, Kyriakis J, Siebenlist U, Kehrl JH. TNF-mediated activation of the SAPK pathway: TRAF2 recruits and activates germinal center kinase related. J Immunol 1999;163:3279-85.
112. Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, et al. Activation of SAPK by MEKK1 phosphorylation of its activator SEK1. Nature 1994;372:798-800.
113. Sanchez I, Huges RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, et al. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 1994;372:794-8.
114. McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, Ling V, et al. ICOS is critical for CD40-mediated antibody class switching. Nature 2001;409:102-5.
115. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997;275:90-4.
116. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 1997;385:540-4.
117. Song HY, Régnier CH, Kirschning CJ, Goeddel DV, Rothe M. TNF-mediated kinase cascades: bifurcation of NF-κB and JNK/SAPK pathways at TRAF2. Proc Natl Acad Sci USA 1997;94:9792-6.
118. Ling L, Cao Z, Goeddel DV. NF-κB inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc Natl Acad Sci USA 1998;95:3792-7.
119. Shinkura R, Kitada K, Matsuda F, Tashiro K, Ikuta K, Suzuki M, et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding NIK. Nat Genet 1999;22:74-7.
120. Garceau N, Kosaka Y, Masters S, Hambor J, Shinkura R, Honjo T, et al. Lineage-restriced function of NIK in transducing signals via CD40. J Exp Med 2000;191:381-5.
121. Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, et al. Defective LT-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice. Science 2001;291:2162-5.
122. Lee FS, Hagler J, Chen ZJ, Maniatis T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997;38:213-22.
123. Ren CL, Morio T, Fu SM, Geha RS. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J Exp Med 1994;179:673-80.
124. Zhu N, Ramirez LM, Lee RL, Magnuson NS, Bishop GA, Gold MR. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-κB pathway. J Immunol 2002;168:744-54.
125. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995;376:167-70.
126. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck R, et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 1995;80:331-40.
127. Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, et al. Mice deficient in NF-κB/p52 present with defects in humoral responses, GC reactions, and splenic microarchitecture. J Exp Med 1998;187:147-59.
128. H transcription, and Ig class switching. J Immunol 1996;156:183-91.
129. Zelazowski P, Carrasco D, Rosas FR, Moorman MA, Bravo R, Snapper CM. B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching. J Immunol 1997;159:3133-9.
130. Bishop GA, Hsing Y, Hostager BS, Jalukar SV, Ramirez LM, Tomai MA. Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848. J Immunol 2000;165:5552-7.
131. Hsing Y, Bishop GA. Requirement for NF-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J Immunol 1999;162:2804-11.
132. Baccam M, Bishop GA. Membrane-bound CD154, but not anti-CD40 mAbs, induces NF-κB independent B cell IL-6 production. Eur J Immunol 1999;29:3855-66.
133. Baccam M, Woo S, Vinson C, Bishop GA. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes. J Immunol 2003;170:3099-108.
134. Wakatsuki Y, Neurath MF, Max EE, Strober W. The B cell-specific transcription factor BSAP regulates B cell proliferation. J Exp Med 1994;179:1099-108.
135. Linehan LA, Warren WD, Thompson PA, Grusby MJ, Berton MT. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J Immunol 1998;161:302-10.
136. Karras JG, Wang Z, Huo L, Frank DA, Rothstein TL. Induction of STAT protein signaling through the CD40 receptor in B lymphocytes. J Immunol 1997;159:4350-5.
137. Thienes CP, De Monte L, Monticelli S, Busslinger M, Gould HJ, Vercelli D. The transcription factor BSAP enhances both IL-4 and CD40-mediated activation of the human ε germline promoter. J Immunol 1997;158:5874-82.
138. Francis DA, Karras JG, Ke X, Sen R, Rothstein TL. Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int Immunol 1995;7:151-61.
139. Lam EW-F, Glassford J, van der Sman J, Banerji L, Pizzey AR, Thomas SB, et al. Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors. Eur J Immunol 1999;29:539-47.
140. Fujita K, Jumper MD, Meek K, Lipsky PE. Evidence for a CD40 response element, distinct from the IL-4 response element, in the germline ε promoter. Int Immunol 1995;7:1529-33.
141. Richards ML, Katz DH. Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine CD23. Comparison with the germline ε promoter. J Immunol 1997;158:263-72.
142. Bishop GA, Hostager BS. B lymphocyte activation by contact-mediated interactions with T lymphocytes. Curr Opin Immunol 2001;13:278-85.
143. Li Y-Y, Baccam M, Waters SB, Pessin JE, Bishop GA, Koretzky GA. CD40 ligation results in PKC-independent activation of ERK and JNK in resting murine splenic B cells. J Immunol 1996;157:1440-7.
144. Sutherland CL, Heath AW, Pelech SL, Young PR, Gold MR. Differential activation of the ERK, JNK, and p38 MAP kinases by CD40 and the B cell antigen receptor. J Immunol 1996;157: 3381-90.
145. Valentine MA, Licciardi KA. Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40. Eur J Immunol 1992;22:3141-8.
146. Santos-Argumedo L, Gordon J, Heath AW, Howard M. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest. Cell Immunol 1994;156:272-85.
147. An S, Knox KA. Ligation of CD40 rescues Ramos B cells from calcium ionophore and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett 1996;386:115-22.
148. Ning Z, Norton JD, Li J, Murphy JJ. Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and IL-4 receptor: role for inhibition of an early response gene, Berg36. Eur J Immunol 1996;26:2356-63.
149. Hartwig UF, Karlsson L, Peterson PA, Webb SR. CD40 and IL-4 regulate murine CD27L expression. J Immunol 1997;159:6000-8.
150. Jacquot S, Kobata T, Iwata S, Morimoto C, Schlossman SF. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses. J Immunol 1997;159:2652-7.
151. Agematsu K, Hokibara S, Nagumo H, Komiyama A. CD27: a memory B cell marker. Immunol Today 2000;21:204-6.
152. Hintzen RQ, de Jong R, Lens SMA, Brouwer M, Baars P, van Lier RAW. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol 1993;151:2426-35.
153. Agematsu K, Nagumo H, Oguchi Y, Nakazawa T, Fukushima K, Yasui K, et al. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of IL-10 and CD27/CD70 interaction. Blood 1998;91:173-80.
154. Nagumo H, Agematsu K, Shinozaki K, Hokibara S, Ito S, Takamoto M, et al. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J Immunol 1998;161:6496-502.
155. Cerutti A, Schaffer A, Shah S, Zan H, Liou H, Goodwin RG, et al. CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated Ig class switching in non-antigen-selected human B cells. Immunity 1998;9:247-56.
156. + B cells. J Immunol 2000;165:786-94.
157. Stüber E, Neurath M, Calderhead D, Fell HP, Strober W. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 1995;2:507-21.
158. Stüber E, Strober W. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med 1996;183:979-89.
159. Morimoto S, Kanno Y, Tanaka Y, Tokano Y, Hashimoto H, Jacquot S, et al. CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses. J Immunol 2000;164:4097-104.
160. Krammer PH. CD95's deadly mission in the immune system. Nature 2000;407:789-95.
161. Cleary AM, Fortune SM, Yellin MJ, Chess L, Lederman S. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. J Immunol 1995;155:3329-37.
162. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: dual roles for CD40-and CD95-ligands modulated by the B cell antigen receptor. Cell 1996;87:319-29.
163. Koopman G, Keehnen RMJ, Lindhout E, Zhou DFH, de Groot C, Pals ST. GC B cells rescued from apoptosis by CD40 ligation or attachment of FDC, but not by engagement of surface Ig or adhesion receptors, become resistant to CD95-induced apoptosis. Eur J Immunol 1997;27:1-7.
164. Hennino A, Berard M, Casamayor-Pallejà M, Krammer PH, Defrance T. Regulation of the Fas death pathway by FLIP in primary human B cells. J Immunol 2000;165:3023-30.
165. Wang J, Lobito AA, Shen F, Hornung F, Winoto A, Lenardo MJ. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur J Immunol 2000;30:155-63.
166. Manis JP, Tian M, Alt FW. Mechanism and control of class-switch recombination. Trends Immunol 2002;23:31-9.
167. Snapper CM, Marcu KB, Zelazowski P. The Ig class switch: beyond "accessibility". Immunity 1997;6:217-23.
168. Jabara HH, Fu SM, Geha RS, Vercelli D. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 1990;172:1861-4.
169. Lomo J, Blomhoff HK, Jacobsen SE, Krajewski S, Reed JC, Smeland EB. IL-13 in combination with CD40L potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1. Blood 1997;89:4415-24.
170. Hasbold J, Hong JS, Kehry MR, Hodgkin PD. Integrating signals from IFN-γ and IL-4 by B cells: positive and negative effects on CD40L-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a. J Immunol 1999;163:4175-81.
171. Lai YH, Mosmann TR. Mouse IL-13 enhances antibody production in vivo and acts directly on B cells in vitro to increase survival and hence antibody production. J Immunol 1999;162:78-87.
172. Noelle RJ. CD40 and its ligand in host defense. Immunity 1996;4:415-9.